Prescribing overview
A combination expectorant and cough suppressant marketed by Creative Science for dogs and cats. The manufacturer sheet lists guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per tablet.
Temporary symptom relief does not identify the cause of a cough. Confirm the exact combination before prescribing.
Key prescribing checks
- The manufacturer sheet is not a comprehensive veterinary safety monograph or evidence of regulatory approval.
- Human dextromethorphan labeling warns about antidepressant interactions and persistent or secretion-heavy cough; veterinary applicability requires assessment.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Dogs and cats
Manufacturer-described use; regulatory approval not established by reviewed sourcesTemporary relief of cough symptoms
This is the Creative Science combination, not a synonym for every cough medicine.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Guaifenesin is the expectorant component; dextromethorphan is the cough-suppressant component.
Absorption, distribution, metabolism and elimination
Canine and feline pharmacokinetics for this specific combination were not established by the reviewed manufacturer sheet.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Creative Science Cough Tablets
Manufacturer canine/feline product sheet; human dextromethorphan warnings are identified separately.
Contraindications · when not to use
- A comprehensive product-specific contraindication list is not provided by the manufacturer sheet.
Precautions & monitoring
- Persistent or productive cough needs diagnosis; human dextromethorphan labeling cautions about excessive secretions. This is not a species-validated exclusion for this product.
Absence of a manufacturer safety restriction does not establish safety.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
A comprehensive animal adverse-effect profile is not supplied. Human dextromethorphan information describes neurologic and gastrointestinal effects; animal frequency is not established.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
The manufacturer sheet uses small/large animal categories without defining weight boundaries. A patient-specific veterinary regimen has not been entered; confirm the package and prescribing plan.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Compare with other medications and check species →
Creative Science Cough Tablets
Manufacturer canine/feline product sheet; human dextromethorphan warnings are identified separately.
- Human dextromethorphan labeling restricts MAO inhibitors and antidepressant combinations; veterinary review is required.
Monitoring
Assess breathing, cough progression, treatment response and neurologic changes.
Client counseling
Do not substitute another cold/cough product or add an antidepressant without veterinary review. Breathing difficulty warrants urgent care.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Follow the current container for storage, expiry and handling.
Brands, formulations & ingredient identity
Active ingredients
Guaifenesin · Dextromethorphan hydrobromide
Other searchable names: Creative Science · Creative Science Cough Tablets · Cough Tablets · Cough tabs · Guaifenesin dextromethorphan · Dextromethorphan guaifenesin
Confirm this exact strength and full ingredient panel on the current package; other cough products are not automatically equivalent.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Creative Science Cough Tablets
- Formulation
- Oral tablets: guaifenesin 100 mg + dextromethorphan HBr 10 mg per tablet
- Label / product scope
- Dogs · Cats
Manufacturer-specific combination; verify the current package.
Product label / source ↗References & review status
Clinical reference updated October 26, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
